click here to Download 2nd Pre- Connect Congress 2016 Complete Agenda
Conference Day One - 17th November 2016
Panel 1: Exploring conventional and unconventional avenues to enhance pharmaceutical export potential
- Strategising to rise above overdependence on international markets for API sourcing
- Analysing the recent government initiatives to promote pharmaceutical exports
- Assessing the impact of pricing policy on the current export portfolios of Indian companies
Prashant Nagre, Chief Executive Officer,
Fermenta Biotech
Panel 2: Mergers and Acquisition – Driving force for Indian Pharma sector
-
Recent trends & key drivers for M&A
-
Moving beyond traditional Mergers and Acquisition
-
Quantifying the impact of FDI implications on the growth of Indian pharma sector
Sudarshan Jain, Managing Director Healthcare Solutions,
Abbott
Sanjay Singh, Partner, Deal Advisory M&A,
KPMG India
Bhupender Saggu, Pharma Specialist,
Thomson Reuters
Moderator:
Rakesh Bhargava, Chairman,
Fresenius Kabi Oncology Ltd
Panel 3: Biosimilars – The next big thing
-
Expanding the biosimilars research ecosystem to accelerate capitalization on the patent cliff
-
Discussing the CDSCO guidance and its implication on the biosimilar market
-
Demystifying the regulatory pathway to ensure speedier approvals
Kanchana TK, Director General,
OPPI
Panel 4: Quality Compliance – A cultural pre-requisite or external obligation
-
Overcoming the cultural sclerosis in the Indian industry to up the quality game
-
Improvising internal controls to reduce quality related corrective actions
-
Inculcating quality commitments in the pharmaceutical curriculum
CT. Renganathan, Managing Director,
RPG Lifesciences
D G Shah, Secretary General,
IPA
Sanjit Singh Lamba, Managing Director,
Eisai Pharmaceuticals
Ashok Bhattacharya, Managing Director,
Takeda Pharmaceuticals
Powered By
Panel 5: Make in India – A Pharma Perspective
-
Transitioning from Generic to Innovative
-
Examining the investment opportunities and returns from initiative
-
Blending the role of FDI into the Make in India wave
H. G Koshia, Commissioner, Food & Drugs Control Administration,
Gujarat
Mr. Amit Sanghvi, Managing Director,
Shaily Engineering Plastics Limited
Powered By
click here to Download 2nd Pre- Connect Congress 2016 Complete Agenda
Conference Day Two - 18th November 2016
Welcome Coffee & Networking
Opening Remarks by the Chair
Panel Discussion: Is gender diversity genuinely seeing a positive shift in the Indian Pharma Industry
-
Breaking stereotypes: Are some departments more suited to women professionals
- Are we ahead of the global trend in gender equality in the Indian boardrooms
-
Can we have it all? Is the balancing act a myth or a reality
-
Life beyond the glass ceiling : Inspiring young leadership among women professionals joining the workforce
Speakers
Seema Ahuja,
Vice President & Global Head of Communications
Biocon Limited, Bangalore, India
Closing Remarks by the Chair